Works matching IS 09441174 AND DT 2025 AND VI 60 AND IP 3


Results: 15
    1

    Acknowledgements.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 3, p. 392, doi. 10.1007/s00535-025-02229-9
    Publication type:
    Article
    2

    Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.

    Published in:
    2025
    By:
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Kobayashi, Satoshi;
    • Ohba, Akihiro;
    • Ueno, Masayuki;
    • Suzuki, Yuko;
    • Tsumura, Hidetaka;
    • Kimura, Nana;
    • Kawaguchi, Shinya;
    • Kawamoto, Yasuyuki;
    • Nakachi, Kohei;
    • Tsuji, Kunihiro;
    • Kobayashi, Noritoshi;
    • Ashida, Reiko;
    • Okano, Naohiro;
    • Umemoto, Kumiko;
    • Murohisa, Gou;
    • Hosokawa, Ayumu;
    • Asagi, Akinori;
    • Nebiki, Hiroko
    Publication type:
    Correction Notice
    3
    4
    5
    6

    Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 3, p. 265, doi. 10.1007/s00535-024-02193-w
    By:
    • Sawada, Akinari;
    • Hoshikawa, Yoshimasa;
    • Hosaka, Hiroko;
    • Saito, Masahiro;
    • Tsuru, Hirotaka;
    • Kato, Shunsuke;
    • Ihara, Eikichi;
    • Koike, Tomoyuki;
    • Uraoka, Toshio;
    • Kasugai, Kunio;
    • Iwakiri, Katsuhiko;
    • Sifrim, Daniel;
    • Pandolfino, John Erik;
    • Taft, Tiffany H.;
    • Fujiwara, Yasuhiro;
    • Tanaka, Fumio;
    • Ominami, Masaki;
    • Ochiai, Tadashi;
    • Yamamoto, Kei;
    • Hisaki, Yuki
    Publication type:
    Article
    7
    8
    9
    10

    Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 3, p. 356, doi. 10.1007/s00535-024-02186-9
    By:
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Kobayashi, Satoshi;
    • Ohba, Akihiro;
    • Ueno, Masayuki;
    • Suzuki, Yuko;
    • Tsumura, Hidetaka;
    • Kimura, Nana;
    • Kawaguchi, Shinya;
    • Kawamoto, Yasuyuki;
    • Nakachi, Kohei;
    • Tsuji, Kunihiro;
    • Kobayashi, Noritoshi;
    • Ashida, Reiko;
    • Okano, Naohiro;
    • Umemoto, Kumiko;
    • Murohisa, Gou;
    • Hosokawa, Ayumu;
    • Asagi, Akinori;
    • Nebiki, Hiroko
    Publication type:
    Article
    11

    Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology, 2025, v. 60, n. 3, p. 328, doi. 10.1007/s00535-024-02185-w
    By:
    • Miura, Ryoichi;
    • Ono, Atsushi;
    • Nakahara, Hikaru;
    • Shirane, Yuki;
    • Yamaoka, Kenji;
    • Fujii, Yasutoshi;
    • Uchikawa, Shinsuke;
    • Fujino, Hatsue;
    • Murakami, Eisuke;
    • Kawaoka, Tomokazu;
    • Miki, Daiki;
    • Tsuge, Masataka;
    • Kishi, Takeshi;
    • Ohishi, Waka;
    • Sakamoto, Naoya;
    • Arihiro, Koji;
    • Hayes, Clair Nelson;
    • Oka, Shiro
    Publication type:
    Article
    12
    13
    14
    15